Intervention: Modified bone marrow stem cell transplantation
Found 0 matching trials
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
PHASE1
This phase I trial studies the best dose of total body irradiation when giv...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
PHASE2
This phase II trial tests how well a ruxolitinib-based graft versus host di...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
PHASE2
A phase II trial of a reduced intensity conditioned (RIC) allogeneic hemato...